Assignee
RIBOSCIENCE LLC
US·12 granted patents·10 pending applications·42 citations·filing 2012–2024
Top patents by PatentIndex Score
22 records- 0190US9108999B22′, 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2012·Granted Aug 18, 2015·17 cites·21 claims
- 0288US9370569B24′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replicationRIBOSCIENCE LLC·Filed 2015·Granted Jun 21, 2016·8 cites·20 claims
- 0386US9249176B24′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2014·Granted Feb 2, 2016·9 cites·20 claims
- 0484US10953030B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2019·Granted Mar 23, 2021·1 cites·15 claims
- 0583US11351186B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2020·Granted Jun 7, 2022·1 cites·14 claims
- 0681US10682369B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2018·Granted Jun 16, 2020·1 cites·22 claims
- 0781US10092649B24′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replicationRIBOSCIENCE LLC·Filed 2016·Granted Oct 9, 2018·3 cites·19 claims
- 0873US9895442B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2014·Granted Feb 20, 2018·2 cites·24 claims
- 0972US2025041319A1Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1069US2025320204A17-aza bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1167US2021369755A14'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA ReplicationRIBOSCIENCE LLC·Filed 2021·Application pending·0 cites
- 1263US12029744B2Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2020·Granted Jul 9, 2024·0 cites·40 claims
- 1362US2018200280A14'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA ReplicationRIBOSCIENCE LLC·Filed 2017·Application pending·0 cites
- 1461US2024199661A1Bicyclic heteroaryl phosphonate derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1560US2024209005A1Bicyclic heteroaryl boronate derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1648US2022056052A1Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2019·Application pending·0 cites
- 1745US9694028B24′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2016·Granted Jul 4, 2017·0 cites·20 claims
- 1843US9708357B24′-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2012·Granted Jul 18, 2017·0 cites·27 claims
- 1941US2016168186A1Method of Treating Dengue FeverRIBOSCIENCE LLC·Filed 2015·Application pending·0 cites
- 2039US2017232031A1Inhibitors of Zika VirusRIBOSCIENCE LLC·Filed 2017·Application pending·0 cites
- 2137US10358458B24′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replicationRIBOSCIENCE LLC·Filed 2015·Granted Jul 23, 2019·0 cites·15 claims
- 2237US2016237106A14'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replicationRIBOSCIENCE LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RIBOSCIENCE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →